• Explore /
  • Poster
  • / Safety and early efficacy results of a phase Ib study of nivolumab plus trastuzumab with S-1/capecitabine plus oxaliplatin for HER2-positive advanced gastric cancer (Ni-HIGH study).

Safety and early efficacy results of a phase Ib study of nivolumab plus trastuzumab with S-1/capecitabine plus oxaliplatin for HER2-positive advanced gastric cancer (Ni-HIGH study).

Abstract Video & Slides Poster

Authors

null

Daisuke Takahari

The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan

Daisuke Takahari , Hirokazu Shoji , Keiko Minashi , Hiroki Hara , Keisho Chin , Akira Oki , Mariko Ogura , Izuma Nakayama , Ken Kato , Satoru Iwasa , Hidekazu Hirano , Yusuke Amanuma , Naoki Ishizuka , Narikazu Boku , Kensei Yamaguchi

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Cancers of the Esophagus and Stomach and Other GI Cancers

Track

Esophageal and Gastric Cancer,Other GI Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

UMIN000034222

DOI

10.1200/JCO.2022.40.4_suppl.276

Abstract #

276

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Daisuke Takahari

First Author: Yelena Y. Janjigian

First Author: Ilya Tsimafeyeu

First Author: Lin Shen